Fangzhou Inc. , a leader in Internet healthcare solutions, took center stage at the 4th Annual “Internet + Pharma” Service Innovation Conference, held during the 90th PHARMCHINA exhibition in Guangzhou, and presented its AI-powered healthcare ecosystem to over 300 industry experts.
Health Technology Insights: J.D. Power: Gap Grows in Employer-Sponsored Health Plans
The event coincided with China’s accelerated healthcare digitization efforts, including the recently introduced 2025-2030 Pharmaceutical Industry Digital Transformation Implementation Plan which emerged from a collaborative effort among seven regulatory bodies, comprising the Ministry of Industry and Information Technology (“MIIT”), the National Health Commission, the Ministry of Commerce, and other key ministries.
Fangzhou’s founder, chairman, and CEO Dr. Xie Fangmin remarked, “Our H2H (Hospital-to-Home) smart healthcare ecosystem leverages advanced AI tools that align with China’s healthcare industry roadmap and help to improve healthcare accessibility.”
Health Technology Insights: Alamar Biosciences Partners with SciLifeLab to Advance Disease Research
AI-enabled Healthcare
During the keynote session, Guo Zhi, Senior Vice President of Technology at Fangzhou, shared the latest advancements the Company’s AI-driven H2H smart healthcare ecosystem, highlighting its cutting-edge solution to mitigate hallucination risks in medical large language models. He also outlined how AI integration, such as intelligent pre-consultation using its AI assistant, is driving efficiency gains and patient satisfaction across its platform. Guo noted that, “AI is transforming healthcare from labor-intensive to algorithm-driven”, and highlighted Fangzhou’s commitment to addressing China’s twin challenges of an aging population and rapidly growing healthcare needs.
AI Transformation as Strategic Imperative
In recent years, China’s national policies have placed growing emphasis on AI adoption throughout the healthcare sector, marking a clear shift in regulatory and developmental priorities. The recent Implementation Plan positions AI and digital transformation as core requirements for industry advancement. This policy momentum is driving widespread adoption of smart technologies and reshaping the strategic roadmaps of healthcare enterprises nationwide. Looking ahead, Fangzhou remains committed to advancing its mission by deepening AI integration across diverse healthcare settings.
Health Technology Insights: Cardiosense Launches SEISMIC-HF II for AI Heart Failure Care
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
